CARBIDOPA-LEVODOPA COMBINATION IN TREATMENT OF PARKINSON DISEASE

被引：0
|
作者：
BOUNDS, JA [1 ]
HUNT, GM [1 ]
机构：
[1] LOMA LINDA UNIV,LOMA LINDA,CA 92354
来源：
WESTERN JOURNAL OF MEDICINE | 1977年 / 127卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：135 / 136
页数：2
相关论文
共 50 条
  • [1] Extended-release carbidopa-levodopa in Parkinson's disease
    Rascol, Olivier
    [J]. LANCET NEUROLOGY, 2013, 12 (04): : 325 - 326
  • [2] Brasofensine treatment for Parkinson's disease in combination with levodopa/carbidopa
    Frackiewicz, EJ
    Jhee, SS
    Shiovitz, TM
    Webster, J
    Topham, C
    Dockens, RC
    Whigan, D
    Salazar, DE
    Cutler, NR
    [J]. ANNALS OF PHARMACOTHERAPY, 2002, 36 (02) : 225 - 230
  • [3] Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease: Pharmacokinetic and quality-of-life measures
    Pahwa, R
    Lyons, K
    McGuire, D
    Silverstein, P
    Zwiebel, F
    Robischon, M
    Koller, WC
    [J]. MOVEMENT DISORDERS, 1997, 12 (05) : 677 - 681
  • [4] Extended-release oral capsule of carbidopa-levodopa in Parkinson disease
    Margolesky, Jason
    Singer, Carlos
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2017, 11 : 1 - 12
  • [5] EFFICACY AND SAFETY OF CARBIDOPA-LEVODOPA IN TREATMENT OF PARKINSONS-DISEASE
    OTERO, E
    [J]. INVESTIGACION MEDICA INTERNACIONAL, 1978, 5 (01): : 64 - 69
  • [6] CARBIDOPA-LEVODOPA RATIO IN PARKINSONS-DISEASE
    TOURTELLOTTE, WW
    SYNDULKO, K
    POTVIN, AR
    [J]. ARCHIVES OF NEUROLOGY, 1981, 38 (11) : 737 - 738
  • [7] CARBIDOPA-LEVODOPA RATIO IN PARKINSONS-DISEASE
    WEINER, WJ
    NAUSIEDA, PA
    [J]. ARCHIVES OF NEUROLOGY, 1981, 38 (08) : 534 - 534
  • [8] STANDARD CARBIDOPA-LEVODOPA VERSUS CONTROLLED-RELEASE CARBIDOPA-LEVODOPA IN PARKINSONS-DISEASE - A POSTMARKET ANALYSIS
    MANYAM, BV
    SHONKWILER, S
    [J]. CLINICAL NEUROPHARMACOLOGY, 1994, 17 (02) : 128 - 137
  • [9] Safety of IPX066, an extended release carbidopa-levodopa formulation, for the treatment of Parkinson's disease
    Kestenbaum, Meir
    Fahn, Stanley
    [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (05) : 761 - 767
  • [10] Efficacy of carbidopa-levodopa extended-release capsules (IPX066) in the treatment of Parkinson Disease
    Mueller, Thomas
    Moehr, Jan-Dominique
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (18) : 2063 - 2071
12345